Innoviva (INVA) FCF Margin Growth (1y) (2012 - 2026)
Innoviva (INVA) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | -1,935.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,935.00 |
| Sep 30, 2025 | -78.00 |
| Jun 30, 2025 | 19.00 |
| Mar 31, 2025 | -143,059.00 |
| Sep 30, 2024 | 52.00 |
| Jun 30, 2024 | -130,686.00 |
| Mar 31, 2024 | 9,665.00 |
| Sep 30, 2023 | -2,473.00 |
| Jun 30, 2023 | -57,299.00 |
| Mar 31, 2023 | -301,988.00 |
| Sep 30, 2022 | -2,080.00 |
| Jun 30, 2022 | -116,675.00 |
| Mar 31, 2022 | -94,846.00 |
| Sep 30, 2021 | 934.00 |
| Jun 30, 2021 | 298,928.00 |
| Mar 31, 2021 | 526,376.00 |
| Dec 31, 2020 | 1.68 Mn |
| Sep 30, 2020 | -323.00 |
| Jun 30, 2020 | 1,295.00 |
| Mar 31, 2020 | -4,553.00 |